1. N. Phelan, E. Williams, S. Cardamone, M. Lee, M. Creighton, G. Rumsby, G.S. Conway, Screening for mutation in 17 β-hydroxysteroid dehydrogenase and androgen receptor in women presenting with partially virilized 46, XY disorders of sex development. Eur. J. Endocrinol. 172, 745–751 (2015)
2. A. Rosler, S. Silverstein, D.Abelovich, A (R80Q) mutation in 17 β-hydroxysteroid dehydrogenase Type 3 gene among Arabs of Israel is associated with pseudo hermaphroditism in males and normal asymptomatic females. J. Clin. Endocrinol. Metabol 81, 1827–1831 (1996)
3. U. Goebelsmann, R. Horton, J.H. Mestman, J.J. Arce, Y. Nagata, R.M. Nakamura, I.H. Thorneycroft, D.R. Mishell, Male pseudo hermaphroditism due to testicular 17 β-hydroxysteroid dehydrogenase deficiency. J. Clin. Endocrinol. Metab. 36, 867–878 (1973)
4. A. Rosler, A. Belanger, F. Labrie, Mechanisms of Androgen production in male pseudo hermaphroditism due to 17 β-hydroxysteroid dehydrogenase deficiency. J. Clin. Endocrinol. Metab. 75, 773–778 (1992)
5. A. Boehmer, A.O. Brinkmann, L.A. Sandkuijl, D.J. Halley, F. Martinus, N.S. Andersson, F.H. De Jong, H. Kayserili, M.A. De Vroede, B.J. Otten et al. 17 β-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations. J. Clin. Endocrinol. Metab. 84, 4713–4721 (1999)